Cite
HARVARD Citation
Smolen, J. et al. (2017). A randomised phase II study evaluating the efficacy and safety of subcutaneously administered ustekinumab and guselkumab in patients with active rheumatoid arthritis despite treatment with methotrexate. Annals of the rheumatic diseases. 76 (5), pp. 831-839. [Online].